CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026

Neutral
AI Analysis

Summary

The FDA Pharmacy Compounding Advisory Committee will meet on July 23-24, 2026 to discuss bulk drug substances being considered for inclusion on the 503A Bulks List.

Importance:2/10
Sentiment:
0.00
FDA Advisory CommitteePharmacy Compounding503A Bulks ListRegulatory

Read the original article

Published by FDA Drugs (New Approvals & NDA) on July 23, 2026 9:45 AM

Read Original